Press Releases
22 August 2019
LAKEWAY, Texas, Aug. 22, 2019 /PRNewswire/ -- JFL Capital Management, LLC, together with its affiliates and the other participants in its solicitation, the largest stockholder of Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") (NASDAQ: MACK), with ownership of approximately 18.7% of the Company's outstanding shares, announced today that it has issued a le
Read more...22 August 2019
SUMMIT, N.J., Aug. 22, 2019 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today announced it will feature data in 3 presentations and 24 posters on the company's adjuvant and cell-based vaccines for seasonal and pandemic influenza at the Options for the Control of Influenza (OPTIONS X) Conference in Singapore.
Read more...22 August 2019
ENGLEWOOD, Colo., Aug. 22, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a special protocol assessment (SPA) phase three clinical trial titled, "A Randomized, Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of Ampion™ in Adul
Read more...22 August 2019
SAN FRANCISCO, Aug. 22, 2019 /PRNewswire/ -- CrossBay Medical, Inc., today announced that it has received clearance to commercialize its product, the Endometrial Tissue Sampler using CrossGlide™ technology, in Europe by obtaining its CE Mark. The use of this technology allows a novel way to obtain an office-based endometrial b
Read more...22 August 2019
BOCA RATON, Fla., Aug. 22, 2019 /PRNewswire/ -- Celsius Holdings, Inc. (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today announced that the Company is launching its first national guerrilla marketing tour, which will make its way across the U.S. The Live Fit Tour will officially kick off in NYC on September
Read more...22 August 2019
RALEIGH, N.C. and TAMPA, Fla., Aug. 22, 2019 /PRNewswire/ -- More than 22% of North Carolina childr
Read more...22 August 2019
CAMBRIDGE, Mass., Aug. 22, 2019 /PRNewswire/ -- Torque, a clinical-stage immuno-oncology company developing Deep-Primed™ T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today the appointment of Sok Cheng Soh as Chief Financial Officer and Ana Radeljevic as Vice President, Head of Business
Read more...SAN DIEGO, Aug. 22, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable infor
Read more...LOS ANGELES, Aug. 22, 2019 /PRNewswire/ -- Theragun, the leader in percussive therapy, announced the opening of Theragun Reset™ in Los
Read more...MENLO PARK, Calif., Aug. 22, 2019 /PRNewswire/ -- Drawbridge Health today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the OneDraw™ A1C Test System, comprised of the OneDraw Blood Collection Device and the OneDraw A1C Test. The OneDraw A1C Test System is intended for the collection and stabiliza
Read more...